In contrast, in MDS marrow (but not AML), the parenchymal CXCL12+/ALP+ MSC population was significantly expanded and additionally overexpressed CXCL12, providing a more widespread and increased CXCL12 expression. This evidence concerns the gene CXCL12 and myelodysplastic syndrome.